Could a new drug combo wipe out three parasitic diseases at once?
NCT ID NCT07159373
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This large study in Fiji tests whether a new combination of drugs (moxidectin plus two others) can safely treat three common parasitic infections: lymphatic filariasis, scabies, and strongyloidiasis. About 5,100 people will receive either the new combo or the standard treatment once a year for three years. The goal is to see if the new combo clears the infections better and with similar side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
moxidectin (combined with diethylcarbamazine and albendazole)
What this could lead to
If successful, this could provide a safer or more effective way to control and eventually eliminate these parasitic diseases in affected communities.
What could go wrong
This is a large Phase 3 trial, but results may not apply to all regions. Side effects are possible, and the treatment may not work better than the existing option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ministry of Health and Medical Services Fiji
Suva, Fiji
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact